Adhesive capsulitis Musculoskeletal Diseases Adhesive capsulitis of shoulder
Conditions
Interventions
Changes to pain, strength and shoulder range of movement are assessed over a 3 month period following one of two two groups:
Group 1. Steroid injection
Group 2. Steroid injection and hydrodilatation
Sponsors
Joint Research Office (part of the Research Support Centre) UCL
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Clinical diagnosis of adhesive capsulitis 2. Normal radiograph of the shoulder 3. Restriction of range of motion compared to unaffected shoulder of at least 30 degrees in 2 of three movements; forward flexion, abduction, and external rotation in neutral measured with a goniometer. 4. Able to give informed consent 5. Diabetic, thyroid or post traumatic (e.g. post dislocation) causes may be included (otherwise slower to recruit numbers). 6. Symptoms for any period of time as long as it can be recorded 7. All patients presenting with adhesive capsulitis should be considered for the trial, but it’s the clinician’s choice if they wish to offer other treatments.
Exclusion criteria
Exclusion criteria: 1. Patients unable to complete questionnaires 2. Patients under 18 or over 85 3. Any surgical intervention for adhesive capsulitis already performed 4. Pre-existing major trauma or surgery to the shoulder 5. Patients with known or suspected musculoskeletal infection in affected shoulder 6. Patients with known or suspected malignancy 7. Steroid injection to affected shoulder less than six weeks at time of proposed intervention 8. Patient on oral steroids 9. Azathioprin, other DMD disease modifying drugs and medication taken after the intervention, in the periods of 6 weeks and 3 months.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Assessed prior to intervention, after 6 weeks and then 3 months post-intervention: 1. Oxford Shoulder Score (OSS) patient-based questionnaire 2. Visual Acuity Score (VAS) 3. Range of motion (ROM) tests using video analysis 4. Change in strength tested using an isokinetic machine | — |
Secondary
| Measure | Time frame |
|---|---|
| Assess patient acceptability of procedural discomfort and satisfaction with results by questionnaire. | — |
Countries
United Kingdom
Outcome results
None listed